Granuloma annulare following initiation of interleukin-17a antagonist

Clin Exp Dermatol. 2021 Jul;46(5):924-926. doi: 10.1111/ced.14579. Epub 2021 Feb 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Drug Eruptions / etiology*
  • Female
  • Granuloma Annulare / chemically induced*
  • Humans
  • Interleukin-17 / antagonists & inhibitors*
  • Middle Aged
  • Psoriasis / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Interleukin-17
  • ixekizumab
  • secukinumab